Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CLGN CollPlant Biotechnologies Ltd Ordinary Shares
$3.75 2.18% +0.08
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CLGN stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

CollPlant Biotechnologies Ltd Ordinary Shares (CLGN)

Loading

Key Stats

Market cap. 7.1M
Enterprise value 5.4M
Trailing PE -3.9893617021277
Forward PE -9.410257
PEG Ratio -0.05186170212766
Enterprise to EBITDA -0.467
Enterprise to revenue 16.987
Price to book MRQ 1.799902
Price to sales TTM 21.82174

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 318.0K
EBITDA -11559000
Diluted EPS TTM -9.33
Total Cash (MRQ) 2.6M
Current ratio (MRQ) 1.567
Operating Cash Flow (TTM) -11194000

CLGN trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CLGN News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.